AACR releases 2017 cancer progress report

September 14, 2017

(HealthDay)—The age-adjusted U.S. cancer death rate decreased 25 percent from 1991 to 2014, which translates into 2.1 million fewer cancer deaths, according to an annual progress report published by the American Association for Cancer Research.

The AACR Cancer Progress Report 2017 provides an overview of the progress being made because of research, as well as the need for continued research innovation.

According to the report, a rapid pace of research in the field of immunology has facilitated development of lifesaving immunotherapeutics. As of July 2017, immunotherapeutics were approved for treating seven different types of cancer and for treatment of solid tumors characterized by the presence of a specific molecular signature or biomarker. New and expanded uses for immunotherapeutics include for Lynch syndrome, Merkel cell carcinoma, and head and neck cancer. From Aug. 1, 2016, to July 31, 2017, the U.S. Food and Drug Administration approved nine new anticancer therapeutics, a new optical imaging agent to help visualize cancerous tissue during surgery, and new uses for eight previously approved therapeutics. New therapeutics targeting specific molecules involved in the cancer process include a PARP inhibitor for ovarian cancer, a PDGFR-alpha-targeted therapeutic for , and the first FLT3 inhibitor for .

"As research has taught us more about the biology of cancer, we have made incredible advances in cancer treatment and prevention that are saving lives today," Michael A. Caligiuri, M.D., president of the AACR, said in a statement.

Explore further: Drug combination boost PARP inhibitor response in resistant ovarian cancer

More information: AACR Cancer Progress Report 2017

Related Stories

Drug combination boost PARP inhibitor response in resistant ovarian cancer

April 3, 2017
About one-third of patients with ovarian cancer who wouldn't be expected to respond to a PARP inhibitor had partial shrinkage of their tumor when a kinase inhibitor was added to treatment, report scientists from Dana-Farber ...

More cancer patients gaining from immune-based treatments

September 20, 2016
(HealthDay)—A leading cancer group says more Americans are benefiting from immunotherapy—a relatively new treatment approach that helps the immune system target and destroy cancer cells.

Americans support more funding of cancer research

September 16, 2015
(HealthDay)—Major advances have been made in the fight against cancer, but Americans aren't satisfied, a new survey suggests.

Some head and neck cancer patients benefit from continued checkpoint inhibitor treatment

April 3, 2017
New research suggests that some patients with head and neck cancers can benefit by continuing treatment with an immunotherapy drug after their tumors show signs of enlargement according to investigators at Dana-Farber Cancer ...

Brain cancer now leading childhood cancer killer

September 16, 2016
Brain cancer is now the deadliest childhood cancer in the U.S., now ahead of leukemia, a result of improved leukemia treatment and a frustrating lack of progress on brain cancer.

Promising cancer treatment targets rare genetic flaw

June 4, 2017
An experimental cancer medicine called larotrectinib has shown promise treating a diverse range of cancers in people young and old, researchers said at a major cancer conference in the United States.

Recommended for you

Breast cancer fuelled by mysterious Yin Yang protein

July 23, 2018
Scientists have unveiled clues about a mysterious molecule called Yin Yang1—and revealed it may fuel tumour growth in breast cancer.

Daily low-dose aspirin may be weapon against ovarian cancer

July 20, 2018
(HealthDay)— One low-dose aspirin a day could help women avoid ovarian cancer or boost their survival should it develop, two new studies suggest.

Discovery of kidney cancer driver could lead to new treatment strategy

July 19, 2018
University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change ...

High fruit and vegetable consumption may reduce risk of breast cancer, especially aggressive tumors

July 19, 2018
Women who eat a high amount of fruits and vegetables each day may have a lower risk of breast cancer, especially of aggressive tumors, than those who eat fewer fruits and vegetables, according to a new study led by researchers ...

Sunscreen reduces melanoma risk by 40 per cent in young people

July 19, 2018
A world-first study led by University of Sydney has found that Australians aged 18-40 years who were regular users of sunscreen in childhood reduced their risk of developing melanoma by 40 percent, compared to those who rarely ...

Analysis of prostate tumors reveals clues to cancer's aggressiveness

July 19, 2018
Using genetic sequencing, scientists have revealed the complete DNA makeup of more than 100 aggressive prostate tumors, pinpointing important genetic errors these deadly tumors have in common. The study lays the foundation ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.